| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,456,000 | 1,348,000 | 1,964,000 | 2,138,000 | | Cost of Revenue | 481,000 | 1,501,000 | 1,288,000 | 1,599,000 | | | Gross Profit | 975,000 | (153,000) | 676,000 | 539,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 801,000 | (261,000) | 302,000 | 17,000 | | Non Recurring | 18,000 |
-
|
-
|
-
| | Others | 83,000 | 79,000 | 74,000 | 77,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 91,000 | 29,000 | 300,000 | 445,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 27,000 | (7,000) | 14,000 | 5,000 | | Earnings Before Interest And Taxes | 100,000 | 22,000 | 314,000 | 450,000 | | Interest Expense | 74,000 | 67,000 | 56,000 | 81,000 | | Income Before Tax | 26,000 | (45,000) | 258,000 | 369,000 | | Income Tax Expense | 17,000 | (43,000) | 67,000 | 122,000 | | Minority Interest | (1,000) |
-
|
-
| (1,000) | | | | Net Income From Continuing Ops | 9,000 | (2,000) | 191,000 | 246,000 | | | Non-recurring Events | | Discontinued Operations | (24,000) | (29,000) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (16,000) | (31,000) | 191,000 | 246,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($16,000) | ($31,000) | $191,000 | $246,000 |
|
0.29% Nasdaq 
0.12 (0.47%) 
Income Statement
